Explore
Organizations
People
Research
Locations
Focus
Events
Jobs
Clinical Trials
Pubco Index
Investors
Insights
Neuly Insights
Clinical Trial Tracker
Investment Funds
Request Insight
Login
Register
Dashboard
Organizations
People
Investors
Locations
Focus
Research
Clinical Trials
Pubco Index
Events
Jobs
Insights
DISCOVER
Dashboard
Organizations
People
Investors
Locations
Focus
Research
Clinical Trials
Pubco Index
Events
Jobs
Insights
Home
Neuly
Focus
DMT
DMT
Events (1)
Exploring 5-MeO-DMT: Therapeutic Potential, Ethics and the Shadow
Organizations (12)
Research (39)
Human psychopharmacology of N, N-dimethyltryptamine
The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator
N, N-dimethyltryptamine: an endogenous hallucinogen
A dimethyltryptamine-forming enzyme in human blood
The psychedelic model of schizophrenia: the case of N, N-dimethyltryptamine
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids
Dose-response study of N, N-dimethyltryptamine in humans: I. Neuroendocrine, autonomic, and cardiovascular effects
Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine
Dose-response study of N, N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale
Effects of 5-methoxy-N, N-dimethyltryptamine on central monoamine neurons
Hydroxylation and N-demethylation of N, N-dimethyltryptamine
Behavioral effects of 5-methoxy-N: N-dimethyltryptamine, other tryptamines, and LSD
A Fatal Intoxication Following the Ingestion of 5-Methoxy-N,N-Dimethyltryptamine in an Ayahuasca Preparation
When the endogenous hallucinogenic trace amine N, N-dimethyltryptamine meets the sigma-1 receptor
Quantitation of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Plasma after Oral Dosing with Ayahuasca
Dimethyltryptamine experiments with psychotics
Agonist properties of N, N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors
Neuropharmacology of N, N-dimethyltryptamine
DISCARNATE ENTITIES AND DIMETHYLTRYPTAMINE (DMT): PSYCHOPHARMACOLOGY, PHENOMENOLOGY AND ONTOLOGY.
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies
Differential tolerance to biological and subjective effects of four closely spaced doses of N, N-dimethyltryptamine in humans
Metabolism of the hallucinogen N, N-dimethyltryptamine in rat brain homogenates
In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N, N-dimethyltryptamine in the rat
Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N, N-dimethyltryptamine in the rat
Psychedelic 5-methoxy-N, N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions
Dimethyltryptamine levels in blood of schizophrenic patients and control subjects
Programmed communication during experiences with DMT (dimethyltryptamine)
Studies on the mechanism of action of monoamine oxidase: metabolism of N, N-dimethyltryptamine and N, N-dimethyltryptamine-N-oxide
Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter
t-Amine oxide rearrangements. N, N-Dimethyltryptamine oxide
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N, N-dimethyltryptamine in rats treated with a monoamine …
Blood and urine levels of N, N-dimethyltryptamine following administration of psychoactive dosages to human subjects
Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N, N-dimethyltryptamine
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 …
N,N-dimethyltryptamine and the pineal gland: Separating fact from myth
The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide
Determination of N, N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca
Clinical Trials (7)
UW Psilocybin Pharmacokinetics Study
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Psychopharmacology of Psilocybin in Cancer Patients
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Psilocybin Cancer Anxiety Study
Effects of Dimethyltryptamine in Healthy Subjects
Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
×
Loading...
Neuly Feedback
Neuly Menu
Explore
Organizations
People
Research
Locations
Focus
Events
Jobs
Clinical Trials
Pubco Index
Investors
Insights
Neuly
About Us
What Data is Included
Create a Profile
Coming soon!
Dashboard
Register
/
Login
Give Feedback
We got it - thanks so much for your feedback!
Title:
Type:
General Feedback
Bug / Problem
Suggestion
Feature Request
Message:
Please login to submit feedback
Login